Pharmocann Global Ltd engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes. It provides cannabis to treat patients with depression, post-trauma, anxiety disorders, and obsessive-compulsive disorder. The company produces 4 tons of processed cannabis. It operates in Israel, Australia, Asia, Europe, the United States, and Canada. It also produces and distributes hemp based cosmetic and seed oil products. The company was formerly known as Medical Compression System (DBN) Ltd. Pharmocann Global Ltd was incorporated in 1997 and is headquartered in Kiryat Tivon, Israel.
History
Pharmocann was founded in 2016 in Oakland, California, with the goal of changing the cannabis industry forever. The company has since grown from a team of 3 to more than 300 in California, Illinois, and Massachusetts, operating more than 25 dispensaries and growing over 300 strains of cannabis.
Mission
Pharmocann is dedicated to providing safe, reliable cannabis products to patients, practitioners, and other businesses. We strive to advance the cannabis industry through research, education, and advocacy.
Vision
At Pharmocann, our vision is to become the leader in the cannabis industry by providing reliable access to high-quality cannabis with sustainability and integrity.
Key Team
Mr. Dan Eidelman (VP of Strategy)
Mr. Yoni Shukrun (Exec. Officer)
Recognition and Awards
Pharmocann has received awards from the National Cannabis Industry Association, Cannabis Business Awards, High Times, and Cannabis World Congress and Business Exposition.